New York, July 03, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Recombinant DNA Technology Industry" - https://www.reportlinker.com/p06032744/?utm_source=GNW
Medical, one of the segments analyzed in the report, is projected to record 5.2% CAGR and reach US$70.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Non-Medical segment is readjusted to a revised 3.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $18.9 Billion, While China is Forecast to Grow at 4.4% CAGR
The Recombinant DNA Technology market in the U.S. is estimated at US$18.9 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$16.5 Billion by the year 2030 trailing a CAGR of 4.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.2% and 3.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.
Select Competitors (Total 32 Featured)
- Amgen Inc
- Bamboo Therapeutics, Inc.
- Biocon
- Biogen
- Chiron Corporation
- Cibus
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- Genentech, Inc
- GenScript
- GlaxoSmithKline plc.
- Horizon Discovery Group plc
- Merck KGaA
- Monsanto Company
- New England Biolabs
- Novartis AG
- Novo Nordisk A/S
- Nucelis
- Pfizer Inc.
- Profacgen
- Sanofi
- Syngene
Read the full report: https://www.reportlinker.com/p06032744/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Recombinant DNA Technology - Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recombinant DNA Technology Market Analysis of
Annual Sales in US$ Million for Years 2014 through 2030
Table 2: World Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 3: World Historic Review for Recombinant DNA Technology
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 4: World 16-Year Perspective for Recombinant DNA
Technology by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2014, 2023 & 2030
Table 5: World Recent Past, Current & Future Analysis for
Medical by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR
Table 6: World Historic Review for Medical by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 7: World 16-Year Perspective for Medical by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030
Table 8: World Recent Past, Current & Future Analysis for
Non-Medical by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR
Table 9: World Historic Review for Non-Medical by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR
Table 10: World 16-Year Perspective for Non-Medical by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030
Table 11: World Recent Past, Current & Future Analysis for
Expression System by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 12: World Historic Review for Expression System by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 13: World 16-Year Perspective for Expression System by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030
Table 14: World Recent Past, Current & Future Analysis for
Cloning Vector by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 15: World Historic Review for Cloning Vector by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 16: World 16-Year Perspective for Cloning Vector by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030
Table 17: World Recent Past, Current & Future Analysis for
Health & Disease by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 18: World Historic Review for Health & Disease by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 19: World 16-Year Perspective for Health & Disease by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030
Table 20: World Recent Past, Current & Future Analysis for Food &
Agriculture by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR
Table 21: World Historic Review for Food & Agriculture by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 22: World 16-Year Perspective for Food & Agriculture by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030
Table 23: World Recent Past, Current & Future Analysis for
Environmental by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR
Table 24: World Historic Review for Environmental by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR
Table 25: World 16-Year Perspective for Environmental by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030
Table 26: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR
Table 27: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 28: World 16-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
Recombinant DNA Technology Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United States for 2023
(E)
Table 29: USA Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 30: USA Historic Review for Recombinant DNA Technology by
Product Type - Medical and Non-Medical Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 31: USA 16-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2014, 2023 &
2030
Table 32: USA Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 33: USA Historic Review for Recombinant DNA Technology by
Type - Expression System and Cloning Vector Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 34: USA 16-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2014, 2023 &
2030
Table 35: USA Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Application - Health & Disease,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 36: USA Historic Review for Recombinant DNA Technology by
Application - Health & Disease, Food & Agriculture,
Environmental and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 37: USA 16-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2014, 2023 & 2030
CANADA
Table 38: Canada Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 39: Canada Historic Review for Recombinant DNA Technology
by Product Type - Medical and Non-Medical Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 40: Canada 16-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2014, 2023 &
2030
Table 41: Canada Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 42: Canada Historic Review for Recombinant DNA Technology
by Type - Expression System and Cloning Vector Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 43: Canada 16-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2014, 2023 &
2030
Table 44: Canada Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Application - Health & Disease,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 45: Canada Historic Review for Recombinant DNA Technology
by Application - Health & Disease, Food & Agriculture,
Environmental and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 46: Canada 16-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2014, 2023 & 2030
JAPAN
Recombinant DNA Technology Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 47: Japan Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 48: Japan Historic Review for Recombinant DNA Technology
by Product Type - Medical and Non-Medical Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 49: Japan 16-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2014, 2023 &
2030
Table 50: Japan Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 51: Japan Historic Review for Recombinant DNA Technology
by Type - Expression System and Cloning Vector Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 52: Japan 16-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2014, 2023 &
2030
Table 53: Japan Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Application - Health & Disease,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 54: Japan Historic Review for Recombinant DNA Technology
by Application - Health & Disease, Food & Agriculture,
Environmental and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 55: Japan 16-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2014, 2023 & 2030
CHINA
Recombinant DNA Technology Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in China for 2023 (E)
Table 56: China Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 57: China Historic Review for Recombinant DNA Technology
by Product Type - Medical and Non-Medical Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 58: China 16-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2014, 2023 &
2030
Table 59: China Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 60: China Historic Review for Recombinant DNA Technology
by Type - Expression System and Cloning Vector Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 61: China 16-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2014, 2023 &
2030
Table 62: China Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Application - Health & Disease,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 63: China Historic Review for Recombinant DNA Technology
by Application - Health & Disease, Food & Agriculture,
Environmental and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 64: China 16-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2014, 2023 & 2030
EUROPE
Recombinant DNA Technology Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 65: Europe Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Geographic Region - France,
Germany, Italy, UK and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR
Table 66: Europe Historic Review for Recombinant DNA Technology
by Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR
Table 67: Europe 16-Year Perspective for Recombinant DNA
Technology by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2014, 2023 & 2030
Table 68: Europe Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 69: Europe Historic Review for Recombinant DNA Technology
by Product Type - Medical and Non-Medical Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 70: Europe 16-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2014, 2023 &
2030
Table 71: Europe Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 72: Europe Historic Review for Recombinant DNA Technology
by Type - Expression System and Cloning Vector Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 73: Europe 16-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2014, 2023 &
2030
Table 74: Europe Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Application - Health & Disease,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 75: Europe Historic Review for Recombinant DNA Technology
by Application - Health & Disease, Food & Agriculture,
Environmental and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 76: Europe 16-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2014, 2023 & 2030
FRANCE
Recombinant DNA Technology Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in France for 2023 (E)
Table 77: France Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 78: France Historic Review for Recombinant DNA Technology
by Product Type - Medical and Non-Medical Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 79: France 16-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2014, 2023 &
2030
Table 80: France Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 81: France Historic Review for Recombinant DNA Technology
by Type - Expression System and Cloning Vector Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 82: France 16-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2014, 2023 &
2030
Table 83: France Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Application - Health & Disease,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 84: France Historic Review for Recombinant DNA Technology
by Application - Health & Disease, Food & Agriculture,
Environmental and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 85: France 16-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2014, 2023 & 2030
GERMANY
Recombinant DNA Technology Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 86: Germany Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 87: Germany Historic Review for Recombinant DNA
Technology by Product Type - Medical and Non-Medical Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 88: Germany 16-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2014, 2023 &
2030
Table 89: Germany Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 90: Germany Historic Review for Recombinant DNA
Technology by Type - Expression System and Cloning Vector
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 91: Germany 16-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2014, 2023 &
2030
Table 92: Germany Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Application - Health & Disease,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 93: Germany Historic Review for Recombinant DNA
Technology by Application - Health & Disease, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 94: Germany 16-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2014, 2023 & 2030
ITALY
Table 95: Italy Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 96: Italy Historic Review for Recombinant DNA Technology
by Product Type - Medical and Non-Medical Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 97: Italy 16-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2014, 2023 &
2030
Table 98: Italy Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 99: Italy Historic Review for Recombinant DNA Technology
by Type - Expression System and Cloning Vector Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 100: Italy 16-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2014, 2023 &
2030
Table 101: Italy Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Application - Health & Disease,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 102: Italy Historic Review for Recombinant DNA Technology
by Application - Health & Disease, Food & Agriculture,
Environmental and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 103: Italy 16-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2014, 2023 & 2030
UNITED KINGDOM
Recombinant DNA Technology Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United Kingdom for 2023
(E)
Table 104: UK Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 105: UK Historic Review for Recombinant DNA Technology by
Product Type - Medical and Non-Medical Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 106: UK 16-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2014, 2023 &
2030
Table 107: UK Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 108: UK Historic Review for Recombinant DNA Technology by
Type - Expression System and Cloning Vector Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 109: UK 16-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2014, 2023 &
2030
Table 110: UK Recent Past, Current & Future Analysis for
Recombinant DNA Technology by Application - Health & Disease,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 111: UK Historic Review for Recombinant DNA Technology by
Application - Health & Disease, Food & Agriculture,
Environmental and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR
Table 112: UK 16-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2014, 2023 & 2030
REST OF EUROPE
Table 113: Rest of Europe Recent Past, Current & Future
Analysis for Recombinant DNA Technology by Product Type -
Medical and Non-Medical - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR
Table 114: Rest of Europe Historic Review for Recombinant DNA
Technology by Product Type - Medical and Non-Medical Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 115: Rest of Europe 16-Year Perspective for Recombinant
DNA Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2014, 2023 &
2030
Table 116: Rest of Europe Recent Past, Current & Future
Analysis for Recombinant DNA Technology by Type - Expression
System and Cloning Vector - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 117: Rest of Europe Historic Review for Recombinant DNA
Technology by Type - Expression System and Cloning Vector
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 118: Rest of Europe 16-Year Perspective for Recombinant
DNA Technology by Type - Percentage Breakdown of Value Sales
for Expression System and Cloning Vector for the Years 2014,
2023 & 2030
Table 119: Rest of Europe Recent Past, Current & Future
Analysis for Recombinant DNA Technology by Application - Health &
Disease, Food & Agriculture, Environmental and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 120: Rest of Europe Historic Review for Recombinant DNA
Technology by Application - Health & Disease, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 121: Rest of Europe 16-Year Perspective for Recombinant
DNA Technology by Application - Percentage Breakdown of Value
Sales for Health & Disease, Food & Agriculture, Environmental
and Other Applications for the Years 2014, 2023 & 2030
ASIA-PACIFIC
Recombinant DNA Technology Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 122: Asia-Pacific Recent Past, Current & Future Analysis
for Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 123: Asia-Pacific Historic Review for Recombinant DNA
Technology by Product Type - Medical and Non-Medical Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 124: Asia-Pacific 16-Year Perspective for Recombinant DNA
Technology by Product Type - Percentage Breakdown of Value
Sales for Medical and Non-Medical for the Years 2014, 2023 &
2030
Table 125: Asia-Pacific Recent Past, Current & Future Analysis
for Recombinant DNA Technology by Type - Expression System and
Cloning Vector - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 126: Asia-Pacific Historic Review for Recombinant DNA
Technology by Type - Expression System and Cloning Vector
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 127: Asia-Pacific 16-Year Perspective for Recombinant DNA
Technology by Type - Percentage Breakdown of Value Sales for
Expression System and Cloning Vector for the Years 2014, 2023 &
2030
Table 128: Asia-Pacific Recent Past, Current & Future Analysis
for Recombinant DNA Technology by Application - Health &
Disease, Food & Agriculture, Environmental and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 129: Asia-Pacific Historic Review for Recombinant DNA
Technology by Application - Health & Disease, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 130: Asia-Pacific 16-Year Perspective for Recombinant DNA
Technology by Application - Percentage Breakdown of Value Sales
for Health & Disease, Food & Agriculture, Environmental and
Other Applications for the Years 2014, 2023 & 2030
REST OF WORLD
Table 131: Rest of World Recent Past, Current & Future Analysis
for Recombinant DNA Technology by Product Type - Medical and
Non-Medical - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR
Table 132: Rest of World Historic Review for Recombinant DNA
Technology by Product Type - Medical and Non-Medical Markets -
Independent Analysis of Annual Sales in US$ Million for Years
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032744/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
